Eplerenone (Inspra)

eplerenone · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eplerenone (Inspra), covering 2012-02-10 to 2012-02-10. Get the full timeline:

Most recent: Clinical Trial Update: EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion [Phase 2]